Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma

Published:2016-07 Issue:7 Volume:31 Page:1336-1341
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Shao Yu-Yun¹²³,Liu Tsung-Hao³,Lee Ying-Hui³,Hsu Chih-Hung¹³,Cheng Ann-Lii¹²³⁴

Affiliation:

1. Graduate Institute of Oncology; College of Medicine, National Taiwan University; Taipei City Taiwan

2. National Taiwan University Cancer Center; College of Medicine, National Taiwan University; Taipei City Taiwan

3. Department of Oncology; National Taiwan University Hospital; Taipei City Taiwan

4. Department of Internal Medicine; College of Medicine, National Taiwan University; Taipei City Taiwan

Funder

National Science Council, Taiwan

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13312/fullpdf

Reference28 articles.

1. Advanced hepatocellular carcinoma: which staging systems best predict prognosis?;Huitzil-Melendez;J. Clin. Oncol.,2010

2. Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems;Shao;Br. J. Cancer,2012

3. Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials;Collette;Ann. Oncol.,2008

4. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008

5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol.,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proposal of an integrated staging system using albumin-bilirubin grade and serum alpha-fetoprotein values for predicting postoperative prognosis of recurrent hepatocellular carcinoma;European Journal of Surgical Oncology;2024-06

2. Another prognostic marker for hepatocellular carcinoma;Hepatology International;2023-03-31

3. What Is the Impact of Liver Function to Predict Mortality in Patients with Severe Aortic Stenosis and Reduced Ejection Fraction?;Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology;2023

4. Bevacizumab and atezolizumab as first-line therapy for advanced hepatocellular carcinoma: A Taiwanese subgroup analysis on efficacy and safety;Journal of the Formosan Medical Association;2022-12

5. Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma;Journal of Vascular and Interventional Radiology;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3